title: Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study.
abstract: The efficacy, safety, and tolerability of subcutaneous sumatriptan in the acute treatment of cluster headache were investigated in a multicenter study over a period of up to 1 year. A total of 2,031 attacks were evaluated in 52 patients. Therapy was successful in 88% of all attacks. Freedom from pain within 15 minutes in more than 90% of all attacks treated was reported by 42% of the patients, and no decline in efficacy occurred during the course of the study. Adverse events were reported by 62% of the patients.
authors.affiliation: Klinik für Neurologie der Christian-Albrechts-Universität Kiel, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Göbel
authors.forename: V
authors.initials: V
authors.lastname: Lindner
authors.forename: A
authors.initials: A
authors.lastname: Heinze
authors.forename: M
authors.initials: M
authors.lastname: Ribbat
authors.forename: G
authors.initials: G
authors.lastname: Deuschl
mesh_terms: D000328:Adult; D003027:Cluster Headache / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D011446:Prospective Studies; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018170:Sumatriptan